Tebipenem: Oral Carbapenem for the Treatment of Complicated Urinary Tract Infections – Oral Presentation Posted on June 24, 2019 at 3:12 pm.Written by Spero Therapeutics View Presentation Post navigation A GLP 14-Day Repeat Dose Toxicology Study of SPR206 in MonkeysMonitoring the In Vitro Activity of Tebipenem, an Orally Available Carbapenem Agent, against a Current Collection of Surveillance Enterobacteriaceae Clinical Isolates (2018)
